Pope on Glaxo, Novartis

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

July 15 (Bloomberg) -- Stephen Pope, chief global market strategist at Cantor Fitzgerald, talks about the 1.57 billion-pound ($2.4 billion) legal charge GlaxoSmithKline Plc said it expects to settle legal cases including lawsuits that alleged its Avandia diabetes drug led to heart attacks. Pope also discusses Novartis AG's second-quarter results. He speaks with Maryam Nemazee on Bloomberg Television's "Countdown." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change